Type
|
Public company |
---|---|
Traded as | NYSE: GHL S&P 600 Component |
Industry | Investment Banking |
Founded | 1996 (1996) |
Headquarters | 300 Park Avenue (Manhattan) New York City, United States |
Key people
|
Robert F. Greenhill (Chairman and Founder) Scott L. Bok (CEO) |
Products | Investment Banking |
Revenue | $336 million (2016) |
Net income
|
$61 million (2016) |
Website | www.greenhill.com |
Robert F. Greenhill (Chairman and Founder)
Greenhill is an independent, New York based investment bank founded in 1996 by Robert F. Greenhill. It is widely considered to be one of the most elite and prestigious firms on Wall Street, with a formidable M&A practice.
The firm provides advice on mergers, acquisitions, restructurings, financings, and capital raisings to leading corporations, partnerships, institutions and governments across a number of industries. Recent clients include Actavis, Alcoa, Energy Future Holdings, Fluor Corporation, Gannett, GlaxoSmithKline, London Stock Exchange Group, Safeway, Tesco, Teva, and the US Department of Treasury.
Greenhill was established in New York City in 1996 by Robert F. Greenhill, the former President of Morgan Stanley and former Chairman and Chief Executive Officer of Smith Barney. He founded the first M&A group on Wall Street while at Morgan Stanley and became an early pioneer of the industry.
Greenhill has been featured in many prominent assignments since its founding including the $100 billion acquisition of ABN AMRO in 2007, the United States Department of Treasury's divestiture of its $51 billion stake in AIG in 2012, and the $17 billion merger between Northwest Airlines and Delta Air Lines in 2008. The firm was also involved as an adviser to a highly influential group of former Morgan Stanley partners in their successful and controversial bid to have former Morgan Stanley CEO Philip J. Purcell step down in 2005.
Like a number of other independent investment banks, Greenhill has grown by recruiting a significant number of Managing Directors from major investment banks (as well as senior professionals from other institutions). The firm has also expanded globally, opening further offices in North America, Europe, Australasia, Asia and South America.
In May 2004, the firm completed an initial public offering of common stock onto the New York Stock Exchange.
In October 2013, the firm announced that it had opened an office in São Paulo in conjunction with hiring Daniel Wainstein, the former head of Goldman Sachs' Brazilian investment banking business.
In 2014, Greenhill advised on the $25 billion acquisition of Forest Laboratories by Actavis and the $10 billion merger between Safeway and Albertsons. Both transactions were among the ten largest of the year globally.
In January 2015, Greenhill agreed to purchase Cogent Partners, a leading investment bank focused on secondary market advisory for private equity investments.
In July 2015, Greenhill advised Teva Pharmaceuticals on the $40.5 billion acquisition of Allergan plc’s Generics business in one of the largest transactions globally in 2015.
Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-01 | Future report Set alerts | |
Q2 2022 | 2022-08-02 | -1.03 | -1.03 |
Q1 2022 | 2022-04-27 | -0.66 | -0.66 |
Q4 2021 | 2022-02-02 | 1.21 | 1.21 |
Q3 2021 | 2021-11-03 | 0.85 | 0.85 |
Q2 2021 | 2021-08-03 | -0.45 | -0.45 |
Q1 2021 | 2021-04-29 | 0.09 | 0.09 |
Q4 2020 | 2021-02-04 | 2.71 | 2.71 |
Q3 2020 | 2020-11-02 | -0.49 | -0.49 |
Q2 2020 | 2020-07-23 | -0.79 | -0.79 |
2016-06-29 | Reiterated Rating | Credit Suisse | Hold | $13.00 |
2016-06-29 | Reiterated Rating | Credit Suisse Group AG | Hold | $13.00 |
2016-04-08 | Lower Price Target | Credit Suisse | Neutral | $24.00 to $18.00 |
2016-04-06 | Downgrade | Goldman Sachs | Buy to Neutral | $33.00 to $25.00 |
2016-04-06 | Downgrade | Goldman Sachs Group Inc. | Buy to Neutral | $33.00 to $25.00 |
2016-03-15 | Lower Price Target | Nomura | $29.00 to $28.00 | |
2016-03-15 | Lower Price Target | Nomura Holdings Inc. | $29.00 to $28.00 | |
2016-01-29 | Upgrade | Rafferty Capital Markets | Hold to Buy | $27.00 to $34.00 |
2016-01-11 | Boost Price Target | Nomura | Neutral | $26.00 to $28.00 |
2015-12-21 | Initiated Coverage | Buckingham Research | Neutral | $32.00 |
2015-10-23 | Lower Price Target | Susquehanna | $39.00 to $33.00 | |
2015-10-23 | Lower Price Target | Nomura | Neutral | $30.00 to $26.00 |
2015-10-23 | Lower Price Target | Keefe, Bruyette & Woods | $35.00 to $32.00 | |
2015-10-23 | Lower Price Target | Credit Suisse | Neutral | $31.00 |
2015-10-12 | Lower Price Target | Susquehanna | Positive | $46.00 to $39.00 |
2015-10-07 | Lower Price Target | Keefe, Bruyette & Woods | Market Perform | $45.00 to $35.00 |
2015-10-06 | Lower Price Target | Nomura | Neutral | $41.00 to $30.00 |
2015-09-08 | Upgrade | Credit Suisse | Underperform to Neutral | $36.50 to $34.00 |
2015-07-07 | Boost Price Target | Nomura | $41.00 to $42.00 | |
2015-06-25 | Upgrade | Goldman Sachs | Sell to Buy | $41.00 to $48.00 |
2015-04-13 | Boost Price Target | Susquehanna | Positive | $46.00 to $48.00 |
2015-02-18 | Set Price Target | Credit Suisse | Sell | $34.00 to $36.50 |
2015-02-17 | Upgrade | Susquehanna | Neutral to Positive | |
2015-02-02 | Downgrade | Credit Suisse | Neutral to Underperform | $45.00 to $34.00 |
2015-01-29 | Lower Price Target | Keefe, Bruyette & Woods | Market Perform | $50.00 to $42.00 |
2015-01-29 | Lower Price Target | Nomura | Neutral | $44.00 to $38.00 |
2015-01-29 | Lower Price Target | MKM Partners | Neutral | $47.00 to $40.00 |
2015-01-13 | Downgrade | Goldman Sachs | Neutral to Sell | $41.00 to $37.00 |
2014-12-12 | Lower Price Target | Keefe, Bruyette & Woods | Market Perform | $54.00 to $50.00 |
2014-12-11 | Initiated Coverage | MKM Partners | Hold | |
2014-07-29 | Lower Price Target | Susquehanna | $43.00 to $40.00 | |
2014-07-29 | Lower Price Target | Nomura | Neutral | $49.00 to $45.00 |
2014-07-29 | Boost Price Target | Credit Suisse | Neutral | $46.00 to $47.00 |
2014-07-07 | Reiterated Rating | Susquehanna | Neutral | $46.00 to $43.00 |
2014-06-25 | Upgrade | Sandler O'Neill | Hold to Buy | |
2014-05-12 | Boost Price Target | Goldman Sachs | $46.00 to $48.00 | |
2014-05-05 | Upgrade | Rafferty Capital Markets | Hold to Buy | |
2014-04-16 | Upgrade | Nomura | Reduce to Neutral | $49.00 |
2014-03-12 | Initiated Coverage | Sidoti | Neutral | |
2014-01-09 | Initiated Coverage | Nomura | Reduce | $52.00 |
2013-12-10 | Initiated Coverage | Credit Suisse | Neutral | |
2013-10-08 | Lower Price Target | Sandler O'Neill | Hold | $50.00 to $48.00 |
2013-09-17 | Boost Price Target | Susquehanna | Neutral | $43.00 to $46.00 |
2012-10-09 | Initiated | UBS | Neutral | $52 |
2011-10-07 | Upgrade | Ticonderoga | Neutral to Buy | $37 |
2011-07-20 | Upgrade | Ticonderoga | Sell to Neutral | $44 |
2011-02-18 | Downgrade | Ticonderoga | Neutral to Sell | $60 |
2010-09-13 | Downgrade | Ticonderoga | Buy to Neutral | |
2010-03-17 | Upgrade | Keefe Bruyette | Mkt Perform to Outperform | |
2010-03-01 | Upgrade | JMP Securities | Mkt Perform to Mkt Outperform | |
2009-09-30 | Downgrade | Pali Research | Buy to Neutral | |
2009-07-10 | Initiated | William Blair | Outperform | |
2009-04-15 | Initiated | Pali Research | Buy | |
2009-04-14 | Initiated | JMP Securities | Mkt Perform | |
2008-12-30 | Downgrade | Keefe Bruyette | Outperform to Mkt Perform | |
2008-09-12 | Upgrade | Wachovia | Mkt Perform to Outperform | |
2008-06-06 | Downgrade | Wachovia | Outperform to Mkt Perform |
2016-06-29 | Reiterated Rating | Credit Suisse | Hold | $13.00 |
2016-06-29 | Reiterated Rating | Credit Suisse Group AG | Hold | $13.00 |
2016-04-08 | Lower Price Target | Credit Suisse | Neutral | $24.00 to $18.00 |
2016-04-06 | Downgrade | Goldman Sachs | Buy to Neutral | $33.00 to $25.00 |
2016-04-06 | Downgrade | Goldman Sachs Group Inc. | Buy to Neutral | $33.00 to $25.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In GHL 81 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
CAPITAL MANAGEMENT CORP /VA | 2.60M |
BlackRock Fund Advisors | 2.29M |
BAIRD ROBERT W & CO INC /WI/ | 0.90M |
MANAGED ACCOUNT ADVISORS LLC | 0.79M |
BlackRock Institutional Trust Company, N.A. | 0.74M |
ACADIAN ASSET MANAGEMENT LLC | 0.73M |
Vanguard Group, Inc | 0.72M |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 0.61M |
WELLINGTON MANAGEMENT CO LLP | 0.60M |
RUTABAGA CAPITAL MANAGEMENT LLC/MA | 0.56M |
South Dakota Investment Council | 0.50M |
Fisher Asset Management, LLC | 0.44M |
RUSSELL FRANK CO/ | 0.34M |
BlackRock Inc. | 0.28M |
DIMENSIONAL FUND ADVISORS LP | 0.24M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Pacific Coast Energy Co LP | 13.66% (3866497) | GHL / ROYT / |
Greenhill Capital Partners II L P | 13.66% (3866497) | GHL / ROYT / |
GREENHILL & CO INC Director by Deputization | 6.40% (1813387) | GHL / IRDM / |
BOK SCOTT L Chief Executive Officer | 2.74% (776436) | GHL / |
GREENHILL ROBERT F Chairman | 2.05% (579710) | GHL / |
RODRIGUEZ HAROLD J JR Chief Operating Officer | 0.20% (56922) | GHL / |
GOLDSTONE STEVEN F | 0.12% (34002) | CAG / CHEF / GHL / |
Wyles David President | 0.10% (29242) | GHL / |
Costantino Kevin M President | 0.08% (24046) | GHL / |
KEY STEPHEN L | 0.07% (21153) | GHL / |
ROBARDS KAREN P | 0.05% (14435) | ATRC / GHL / |
DANFORTH JOHN C | 0.04% (10485) | CERN / GHL / |
LIU JOHN D | 0.03% (8691) | GHL / WHR / |
BLAKELY ROBERT T | 0.03% (8261) | ALLY / GHL / NRP / WLK / |
Grubb Christopher Thomas Chief Financial Officer | 0.02% (5416) | GHL / |
Solotar Gavin Dean General Counsel | 0.02% (5333) | GHL / |
Moran Patricia Chief Legal Officer | 0.01% (3765) | GHL / |